Stephen M. Condon

64 year

Consumer Services

Health Technology

Process Industries

Profile

Stephen M.
Condon worked as a Principal at Shire ViroPharma, Inc. and Rhone Poulenc Rorer.
He also worked as Vice President-Chemistry at TetraLogic Pharmaceuticals Corp.
Condon holds a doctorate degree from the University of Pennsylvania, a graduate degree from the University of Georgia, and an undergraduate degree from the University of Massachusetts.

Former positions of Stephen M. Condon

Companies	Position	End
Rhone Poulenc Rorer Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.	Corporate Officer/Principal	1999-12-31
Shire ViroPharma, Inc. Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.	Corporate Officer/Principal	-
TETRALOGIC PHARMACEUTICALS CORPORATION	Chief Tech/Sci/R&D Officer	-

See the detail of Stephen M. Condon's experience

Training of Stephen M. Condon

University of Pennsylvania	Doctorate Degree
University of Massachusetts	Undergraduate Degree
University of Georgia	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen M. Condon's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TETRALOGIC PHARMACEUTICALS CORPORATION	Health Technology

Private companies	2
Shire ViroPharma, Inc. Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.	Health Technology
Rhone Poulenc Rorer Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.	Process Industries